Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

95.50 

0.64 0.7%

as of Mar 22 '19

52 Week Range:

68.33 95.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Equity (BVPS) 11.40
10.35
16.13
16.55
19.28
growth rate -9.2% 55.9% 2.6% 16.5%
Earnings BIT 159.70
186.50
309.10
340.00
384.00
growth rate 16.8% 65.7% 10.0% 12.9%
Avg.PE 28.10
40.72
21.60
growth rate 44.9% -47.0%
ROA 6.08
-27.72
10.11
10.48
8.26
6.53
3.63
1.54
2.85
3.04
5.68
growth rate -100.0% 100.0% 3.7% -21.2% -20.9% -44.4% -57.6% 85.1% 6.7% 86.8%
ROE 9.81
-47.88
19.03
18.40
15.54
12.57
7.28
4.88
10.45
10.34
16.97
growth rate -100.0% 100.0% -3.3% -15.5% -19.1% -42.1% -33.0% 114.1% -1.1% 64.1%
ROIC 7.88
-37.35
15.72
16.03
12.16
9.59
5.48
2.60
6.05
5.62
10.31
growth rate -100.0% 100.0% 2.0% -24.1% -21.1% -42.9% -52.6% 132.7% -7.1% 83.5%
Cur. Ratio 1.96
2.02
2.56
2.37
1.80
1.99
1.76
1.97
1.63
1.77
1.74
growth rate 3.1% 26.7% -7.4% -24.1% 10.6% -11.6% 11.9% -17.3% 8.6% -1.7%
Quick Ratio 1.56
1.58
1.86
1.83
1.26
1.42
1.15
1.19
1.13
1.23
1.15
growth rate 1.3% 17.7% -1.6% -31.2% 12.7% -19.0% 3.5% -5.0% 8.9% -6.5%
Leverage 1.56
2.02
1.76
1.75
2.00
1.85
2.17
3.89
3.47
3.33
2.70
growth rate 29.5% -12.9% -0.6% 14.3% -7.5% 17.3% 79.3% -10.8% -4.0% -18.9%
Balance Sheet Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Acct.Receivable 411.00
494.70
515.10
579.30
580.70
growth rate 20.4% 4.1% 12.5% 0.2%
Acct.Payable 112.70
136.30
136.00
167.90
177.30
growth rate 20.9% -0.2% 23.5% 5.6%
Cur.Assets 779.30
1,141.00
1,082.10
1,166.20
1,155.60
growth rate 46.4% -5.2% 7.8% -0.9%
Total Assets 1,751.30
4,457.60
4,262.40
4,528.70
4,360.00
growth rate 154.5% -4.4% 6.3% -3.7%
Cash 99.30
192.80
232.20
231.80
183.00
growth rate 94.2% 20.4% -0.2% -21.1%
Inventory 176.20
267.40
252.00
284.50
291.70
growth rate 51.8% -5.8% 12.9% 2.5%
Cur.Liabilities 442.30
578.80
662.30
658.70
662.40
growth rate 30.9% 14.4% -0.5% 0.6%
Liabilities 944.80
3,300.70
3,026.50
3,163.10
2,743.80
growth rate 249.4% -8.3% 4.5% -13.3%
LT Debt 364.10
2,175.20
1,938.40
2,120.40
1,790.40
growth rate 497.4% -10.9% 9.4% -15.6%
Equity 806.50
1,146.90
1,227.20
1,358.20
1,616.20
growth rate 42.2% 7.0% 10.7% 19.0%
Common Shares 63.00
63.00
64.00
64.00
62.00
60.00
59.00
4.40
4.40
4.40
4.40
growth rate 0.0% 1.6% 0.0% -3.1% -3.2% -1.7% -92.5% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Capital Expenditures 62.70
121.30
83.30
97.50
89.50
growth rate 93.5% -31.3% 17.1% -8.2%
Cash Dividends 34.20
37.10
43.80
46.60
51.80
growth rate 8.5% 18.1% 6.4% 11.2%
Cash From OA 210.30
213.80
281.20
311.10
395.20
growth rate 1.7% 31.5% 10.6% 27.0%
FCF per Share 2.28
1.22
2.96
2.76
2.88
growth rate -46.5% 142.6% -6.8% 4.4%
Sale Purchase of Stock 14.00
14.90
10.00
22.80
growth rate 6.4% -32.9% 128.0%
FCF 168.00
225.00
140.00
153.00
184.00
198.00
147.00
93.00
198.00
213.00
305.00
growth rate 33.9% -37.8% 9.3% 20.3% 7.6% -25.8% -36.7% 112.9% 7.6% 43.2%
Income Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Sales 1,686.10
1,988.20
2,655.20
2,743.70
2,848.00
growth rate 17.9% 33.6% 3.3% 3.8%
Op.Income 159.70
186.50
309.10
340.00
384.00
growth rate 16.8% 65.7% 10.0% 12.9%
IBT 115.20
65.10
138.30
183.00
197.20
growth rate -43.5% 112.4% 32.3% 7.8%
Net Income 60.60
47.70
124.10
133.60
252.40
growth rate -21.3% 160.2% 7.7% 88.9%
EPS 1.85
-6.47
1.97
2.09
1.94
1.74
1.04
0.82
1.86
1.99
3.73
growth rate -100.0% 100.0% 6.1% -7.2% -10.3% -40.2% -21.2% 126.8% 7.0% 87.4%
Gross Profit 779.90
880.30
1,276.90
1,325.40
1,394.20
growth rate 12.9% 45.1% 3.8% 5.2%
R&D 71.90
91.80
133.50
133.70
135.60
growth rate 27.7% 45.4% 0.2% 1.4%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 68.00
87.40
95.60
129.00
79.00
growth rate 28.5% 9.4% 34.9% -38.8%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 511.00
537.90
555.50
580.70
537.90
growth rate 5.3% 3.3% 4.5% -7.4%
Acct.Payable 147.70
159.60
163.40
177.30
168.80
growth rate 8.1% 2.4% 8.5% -4.8%
Cur.Assets 1,118.30
1,201.00
1,221.00
1,155.60
1,136.30
growth rate 7.4% 1.7% -5.4% -1.7%
Total Assets 4,460.50
4,504.70
4,465.40
4,360.00
4,350.30
growth rate 1.0% -0.9% -2.4% -0.2%
Cash 233.70
239.00
246.50
183.00
184.20
growth rate 2.3% 3.1% -25.8% 0.7%
Inventory 298.50
315.10
309.40
291.70
299.90
growth rate 5.6% -1.8% -5.7% 2.8%
Cur.Liabilities 637.30
650.50
770.90
662.40
668.20
growth rate 2.1% 18.5% -14.1% 0.9%
Liabilities 2,996.40
2,994.30
2,956.50
2,743.80
2,798.80
growth rate -0.1% -1.3% -7.2% 2.0%
LT Debt 2,036.30
2,025.60
1,865.30
1,790.40
1,816.50
growth rate -0.5% -7.9% -4.0% 1.5%
Equity 1,457.10
1,510.40
1,508.90
1,616.20
1,551.50
growth rate 3.7% -0.1% 7.1% -4.0%
Common Shares 4.40
4.40
4.40
4.40
4.40
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 27.30
24.10
20.50
17.60
15.00
growth rate -11.7% -14.9% -14.2% -14.8%
Cash Dividends 11.90
13.20
13.30
13.40
13.30
growth rate 10.9% 0.8% 0.8% -0.8%
Cash From OA 93.10
32.50
124.20
145.40
116.00
growth rate -65.1% 282.2% 17.1% -20.2%
Sale Purchase of Stock 9.40
4.10
4.60
growth rate -56.4% 12.2%
FCF 65.80
8.40
103.70
127.80
101.00
growth rate -87.2% 1,134.5% 23.2% -21.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 669.70
710.50
708.60
759.20
683.50
growth rate 6.1% -0.3% 7.1% -10.0%
Op.Income 68.00
87.40
95.60
129.00
79.00
growth rate 28.5% 9.4% 34.9% -38.8%
IBT 30.80
21.50
55.50
89.40
49.60
growth rate -30.2% 158.1% 61.1% -44.5%
Net Income 88.30
28.50
45.20
90.40
42.20
growth rate -67.7% 58.6% 100.0% -53.3%
Gross Profit 319.60
350.40
348.00
376.20
330.00
growth rate 9.6% -0.7% 8.1% -12.3%
R&D 32.30
34.70
33.60
35.00
33.20
growth rate 7.4% -3.2% 4.2% -5.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (82.83)

YOY Growth Grade:

C (54.80)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 30.41 31.40
EPS / Growth 3.04

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.2% 16.2% 16.2%
Future PE 0.01 20.95 20.95
Future EPS 13.66 13.66 13.66
Value Price
MOS %
0.03
-100.0%
70.73
-25.9%
70.73
-25.9%
MOS Price 0.02 35.36 35.36
IRT 11.19 11.19 11.19

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.